Estimation of brain receptor occupancy for trazodone immediate release and once a day formulations

• Үндсэн зохиолчид: Laura Oggianu (Зохиогч), Giorgio Di Dato (Зохиогч), Giorgina Mangano (Зохиогч), Maria Teresa Rosignoli (Зохиогч), Savannah McFeely (Зохиогч), Alice Ban Ke (Зохиогч), Hannah M. Jones (Зохиогч), Alessandro Comandini (Зохиогч)
• Формат: Ном
• Хэвлэсэн: Wiley, 2022-06-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

Abstract Trazodone is approved for the treatment of major depressive disorders, marketed as immediate release (IR), prolonged release, and once a day (OAD) formulation. The different formulations allow different administration schedules and may be useful to facilitate patients' compliance to th...